Workflow
earnings estimate revisions
icon
Search documents
Ingredion (INGR) Q1 Earnings Beat Estimates
ZACKS· 2025-05-06 12:15
Core Viewpoint - Ingredion reported quarterly earnings of $2.97 per share, exceeding the Zacks Consensus Estimate of $2.44 per share, and up from $2.08 per share a year ago, indicating strong performance despite revenue challenges [1][2]. Financial Performance - The company achieved an earnings surprise of 21.72% for the quarter, having surpassed consensus EPS estimates in all of the last four quarters [2]. - Revenues for the quarter were $1.81 billion, which fell short of the Zacks Consensus Estimate by 1.63% and decreased from $1.88 billion year-over-year [3]. Stock Performance and Outlook - Ingredion shares have declined approximately 2.9% year-to-date, compared to a 3.9% decline in the S&P 500 [4]. - The company's earnings outlook is uncertain, with current consensus EPS estimates at $2.82 for the next quarter and $11.07 for the current fiscal year, alongside projected revenues of $1.9 billion and $7.51 billion respectively [8]. Industry Context - The Food - Miscellaneous industry, to which Ingredion belongs, is currently ranked in the top 31% of over 250 Zacks industries, suggesting a favorable industry outlook [9]. - The performance of Ingredion's stock may be influenced by the overall industry outlook, as top-ranked industries tend to outperform lower-ranked ones significantly [9].
Louisiana-Pacific (LPX) Q1 Earnings and Revenues Surpass Estimates
ZACKS· 2025-05-06 12:10
Company Performance - Louisiana-Pacific (LPX) reported quarterly earnings of $1.27 per share, exceeding the Zacks Consensus Estimate of $1.13 per share, but down from $1.53 per share a year ago, representing an earnings surprise of 12.39% [1] - The company posted revenues of $724 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 4.50%, with year-ago revenues also at $724 million [2] - Over the last four quarters, Louisiana-Pacific has consistently surpassed consensus EPS estimates [2] Stock Outlook - The stock has underperformed the market, losing about 15.5% since the beginning of the year compared to the S&P 500's decline of 3.9% [3] - The current consensus EPS estimate for the coming quarter is $1.53 on revenues of $773.6 million, and for the current fiscal year, it is $4.99 on revenues of $2.95 billion [7] Industry Context - The Building Products - Wood industry, to which Louisiana-Pacific belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Louisiana-Pacific's stock performance [5]
Boise Cascade (BCC) Lags Q1 Earnings Estimates
ZACKS· 2025-05-05 23:15
分组1 - Boise Cascade reported quarterly earnings of $1.06 per share, missing the Zacks Consensus Estimate of $1.36 per share, and down from $2.61 per share a year ago, representing an earnings surprise of -22.06% [1] - The company posted revenues of $1.54 billion for the quarter, surpassing the Zacks Consensus Estimate by 5.67%, but down from $1.65 billion year-over-year [2] - Over the last four quarters, Boise Cascade has surpassed consensus revenue estimates four times, but has only exceeded EPS estimates once [2] 分组2 - The stock has underperformed, losing about 19.1% since the beginning of the year, compared to the S&P 500's decline of -3.3% [3] - The current consensus EPS estimate for the coming quarter is $2.29 on revenues of $1.81 billion, and for the current fiscal year, it is $7.97 on revenues of $6.54 billion [7] - The Zacks Industry Rank for Building Products - Wood is currently in the bottom 24% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]
Bright Horizons Family Solutions (BFAM) Q1 Earnings and Revenues Surpass Estimates
ZACKS· 2025-05-05 23:05
Core Viewpoint - Bright Horizons Family Solutions (BFAM) reported quarterly earnings of $0.77 per share, exceeding the Zacks Consensus Estimate of $0.63 per share, and showing an increase from $0.51 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was 22.22%, with the company having surpassed consensus EPS estimates in all four of the last quarters [2] - Revenues for the quarter ended March 2025 were $665.53 million, surpassing the Zacks Consensus Estimate by 0.23%, and up from $622.71 million year-over-year [3] Stock Performance - Bright Horizons shares have increased approximately 15.6% since the beginning of the year, contrasting with a decline of 3.3% in the S&P 500 [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.97 on revenues of $714.34 million, and for the current fiscal year, it is $4.06 on revenues of $2.88 billion [8] - The estimate revisions trend for Bright Horizons is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [7] Industry Context - The Business - Services industry, to which Bright Horizons belongs, is currently in the top 28% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [9]
HealthStream (HSTM) Lags Q1 Earnings and Revenue Estimates
ZACKS· 2025-05-05 22:55
Company Performance - HealthStream reported quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.16 per share, and down from $0.17 per share a year ago, representing an earnings surprise of -12.50% [1][2] - The company posted revenues of $73.49 million for the quarter, missing the Zacks Consensus Estimate by 1.84%, and showing a slight increase from $72.76 million year-over-year [3] Market Position - HealthStream shares have increased approximately 7.1% since the beginning of the year, contrasting with the S&P 500's decline of -3.3% [4] - The current consensus EPS estimate for the upcoming quarter is $0.16 on revenues of $75.07 million, and for the current fiscal year, it is $0.66 on revenues of $304.3 million [8] Industry Outlook - The Internet - Services industry, to which HealthStream belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, indicating potential challenges ahead [9] - The company's favorable estimate revisions trend prior to the earnings release has resulted in a Zacks Rank 2 (Buy), suggesting expected outperformance in the near future [7]
Regal Rexnord (RRX) Q1 Earnings and Revenues Top Estimates
ZACKS· 2025-05-05 22:55
Financial Performance - Regal Rexnord reported quarterly earnings of $2.15 per share, exceeding the Zacks Consensus Estimate of $1.82 per share, and up from $2 per share a year ago, representing an earnings surprise of 18.13% [1] - The company posted revenues of $1.42 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.44%, but down from $1.55 billion year-over-year [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.39 on revenues of $1.48 billion, and for the current fiscal year, it is $9.77 on revenues of $5.85 billion [7] - The estimate revisions trend for Regal Rexnord is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Market Performance - Regal Rexnord shares have declined approximately 28% since the beginning of the year, contrasting with the S&P 500's decline of 3.3% [3] - The Manufacturing - General Industrial industry, to which Regal Rexnord belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, suggesting potential challenges ahead [8]
Paymentus (PAY) Q1 Earnings and Revenues Beat Estimates
ZACKS· 2025-05-05 22:51
Core Viewpoint - Paymentus (PAY) reported quarterly earnings of $0.14 per share, exceeding the Zacks Consensus Estimate of $0.13 per share, and showing an increase from $0.10 per share a year ago, indicating a positive earnings surprise of 7.69% [1] Financial Performance - Paymentus achieved revenues of $275.24 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 10.91%, and up from $184.88 million year-over-year [2] - The company has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Stock Performance - Paymentus shares have increased approximately 5.8% since the beginning of the year, contrasting with the S&P 500's decline of -3.3% [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.15 on revenues of $251.66 million, and for the current fiscal year, it is $0.58 on revenues of $1.06 billion [7] - The estimate revisions trend for Paymentus is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, suggesting expected outperformance in the near future [6] Industry Context - The Financial Transaction Services industry, to which Paymentus belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Adeia (ADEA) Q1 Earnings Match Estimates
ZACKS· 2025-05-05 22:40
Company Performance - Adeia reported quarterly earnings of $0.26 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.25 per share a year ago [1] - The company posted revenues of $87.67 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 4.59%, compared to $83.41 million in the same quarter last year [2] - Over the last four quarters, Adeia has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Movement and Outlook - Adeia shares have declined approximately 9.8% since the beginning of the year, while the S&P 500 has decreased by 3.3% [3] - The future performance of Adeia's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4][6] - The current consensus EPS estimate for the upcoming quarter is $0.35 on revenues of $100.53 million, and for the current fiscal year, it is $1.34 on revenues of $410.71 million [7] Industry Context - The Technology Services industry, to which Adeia belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Adeia's stock performance [5]
James River Group (JRVR) Misses Q1 Earnings and Revenue Estimates
ZACKS· 2025-05-05 22:40
James River Group (JRVR) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -20.83%. A quarter ago, it was expected that this insurance holding company would post a loss of $0.33 per share when it actually produced a loss of $0.99, delivering a surprise of -200%. James River Group share ...
Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates
ZACKS· 2025-05-05 22:35
Company Performance - Ekso Bionics reported a quarterly loss of $0.12 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.11, and an improvement from a loss of $0.20 per share a year ago, indicating a negative earnings surprise of -9.09% [1] - The company posted revenues of $3.38 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 28.95%, and down from $3.76 million in the same quarter last year [2] - Over the last four quarters, Ekso Bionics has not surpassed consensus EPS or revenue estimates [2] Stock Outlook - Ekso Bionics shares have declined approximately 20.8% since the beginning of the year, compared to a decline of -3.3% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.05 on revenues of $6.32 million, and for the current fiscal year, it is -$0.25 on revenues of $23.99 million [7] - The estimate revisions trend for Ekso Bionics is currently unfavorable, resulting in a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Industry Context - The Medical - Instruments industry, to which Ekso Bionics belongs, is currently ranked in the top 28% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]